Wound emergencies: The importance of assessment, documentation, and early treatment using a wound electronic medical record

Ostomy Wound Management

Volumn 55, Issue 5, 2009, Pages 54-61

  Golinko, Michael S ^a   Clark, Sunday ^b   Rennert, Robert ^c   Flattau, Anna ^d   Boulton, Andrew J M ^e,f   Brem, Harold ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Case series; Chronic wounds; Diagnosis; Electronic records; Osteomyelitis

Indexed keywords

AGED; ARTICLE; CASE REPORT; CHRONIC DISEASE; DOCUMENTATION; EARLY DIAGNOSIS; EMERGENCY; FEMALE; HOSPITAL PATIENT; HOSPITAL SUBDIVISIONS AND COMPONENTS; HUMAN; INJURY; MALE; MEDICAL RECORD; METHODOLOGY; MIDDLE AGED; NURSING; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY; SKIN CARE; TIME; WOUND HEALING; ELECTRONIC MEDICAL RECORD; PROCEDURES; VERY ELDERLY; WOUNDS AND INJURIES;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DOCUMENTATION; EARLY DIAGNOSIS; ELECTRONIC HEALTH RECORDS; EMERGENCIES; FEMALE; HOSPITAL UNITS; HUMANS; INPATIENTS; MALE; MIDDLE AGED; NURSING ASSESSMENT; RETROSPECTIVE STUDIES; SKIN CARE; TIME FACTORS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 70450163585     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117:72S-109S. (Pubitemid 44317773)
2. Cho CH, Sung HK, Kim KT, et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci USA. 2006;103:4946-4951.
3. Gibran NS, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res. 2002;108:122-128.
4. Brem H, Stojadinovic O, Diegelmann RF, et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med. 2007;13:30-39. (Pubitemid 46786832)
5. Medicare Coverage Advisory Committee. In; 2005 March 29, 2005; Baltimore, Maryland: Centers for Medicare and Medicaid Services; 2005.
6. McCaig LF, Nawar EW. National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. Adv Data. 2006;23(372):1-29.
7. Agency for Healthcare Research and Quality.Healthcare Cost and Utilization Project. Available at: www.hcupnet.ahrq.gov. Accessed April 25, 2009.
8. Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288-1293. (Pubitemid 44125924)
9. Wipke-Tevis DD, Rantz MJ, Mehr DR, Popejoy L, et al. Prevalence, incidence, management, and predictors of venous ulcers in the long-term care population using the MDS. Adv Skin Wound Care. 2000;13(5):218-224.
10. Russo CA, Steiner C, Spector W. Hospitalizations Related to Pressure Ulcers, 2006. HCUPStatistical Brief #64. Agency for Healthcare Research and Quality. Available at: www.hcupus. ahrq.gov/reports/statbriefs/sb64.pdf. Accessed May 1, 2009.
11. International Working Group on the Diabetic Foot. Epidemiology of diabetic foot infections in a population-based cohort. Paper presented at the International Consensus on the Diabetic Foot. Noordwijkerhout, The Netherlands. May 22-24, 2003.
12. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes management cohort. Diabetes Care. 2003;26:1435-1438. (Pubitemid 36929175)
13. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217-228. (Pubitemid 40095873)
14. Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetesrelated lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2006;49:2634-2641.
15. Faglia E, Clerici G, Clerissi J, et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohortstudy of 564 patients. Eur J Vasc Endovasc Surg. 2006;32:484-490. (Pubitemid 44490321)
16. Vanderwee K, Clark M, Dealey C, Gunningberg L, Defloor T. Pressure ulcer prevalence in Europe: a pilot study. J Eval Clin Pract. 2007;13:227-235. (Pubitemid 46449798)
17. Capon A, Pavoni N, Mastromattei A, Di Lallo D. Pressure ulcer risk in long-term units: prevalence and associated factors. J Advanced Nurs. 2007;58:263-272.
18. Redelings MD, Lee NE, Sorvillo F. Pressure ulcers: more lethal than we thought? Advances Skin Wound Care. 2005;18:367-372.
19. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-1256. (Pubitemid 36444440)
20. Hopf HW, Ueno C, Aslam R, et al. Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen. 2006;14:693-710. (Pubitemid 44951309)
21. Brem H, Jacobs T, Vileikyte L, et al. Wound-healing protocols for diabetic foot and pressure ulcers. Surg Technol Int. 2003;11:85-92.
22. Brem H, Sheehan P, Rosenberg HJ, Schneider JS, Boulton AJ. Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg. 2006;117:193S-209S; discussion 10S-11S. (Pubitemid 44317785)
23. Brem H, Kirsner RS, Falanga V. Protocol for the successful treatment of venous ulcers. Am J Surg. 2004;188:1-8. (Pubitemid 38625981)
24. Robson MC, Cooper DM, Aslam R, et al. Guidelines for the treatment of venous ulcers. Wound Repair Regen. 2006;14:649-662. (Pubitemid 44951306)
25. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 2006;14:680-692. (Pubitemid 44951308)
26. Whitney J, Phillips L, Aslam R, et al. Guidelines for the treatment of pressure ulcers. Wound Repair Regen. 2006;14:663-679. (Pubitemid 44951307)
27. Brem H, Young J, Tomic-Canic M, Isaacs C, Ehrlich HP. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int. 2003;11:23-31.
28. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24:290-295. (Pubitemid 32119127)
29. De Martinis M, Modesti M, Ginaldi L. Phenotypic and functional changes of circulating monocytes and polymorphonuclear leucocytes from eld.erly persons. Immunol Cell Biol. 2004;82:415-420 (Pubitemid 39141765)
30. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47:457-463. (Pubitemid 28104210)
31. Center for Medicare and Medicaid Services Manual System. State Operations Provider Certification. [Pub.100-07] 2006. Available at: www.cms.hhs.gov/ manuals/Downloads/som107ap-pp-guidelines-ltcf.pdf. Accessed January 20, 2007.